Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus

CABA-201 data package and experience from prior autoimmune cell therapy INDs informed Phase 1/2 clinical trial design, including the initial dose to be eva...

March 31, 2023 | Friday | News
Suing an Emergency Room for Medical Malpractice

Going to an emergency room can be frightening. Patients are in a vulnerable position and need the care of medical professionals to get through their health...

March 31, 2023 | Friday | News
AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production

This technology offers several advantages over traditional batch purification including: Higher peptide purity Increased yield Decreased solvent requi...

March 29, 2023 | Wednesday | News
TandemAI launches TandemViz™ 1.0 - a web-based GUI for integrated computational analysis and experimental data

TandemAI today announced the release of TandemViz™ 1.0, the company’s proprietary web-based platform that provides its growing roster of drug d...

March 29, 2023 | Wednesday | News
Suppliers’ supply chain and continuous manufacturing are the big risk & resilience issues for US CDMOs

With many of the largest CDMOs now running at capacity, drug sponsors will need to focus on mitigating risk and building resiliency when using smaller or m...

March 29, 2023 | Wednesday | News
Willow Biosciences Announces Changes to Board and Management

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing indust...

March 29, 2023 | Wednesday | News
Healthcare Revolution: Medical Tourism and the American Dream

This year's Healthcare Revolution is about the failings of the American Dream with rising and unsustainable healthcare costs, and how employers can navigat...

March 29, 2023 | Wednesday | News
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | Tuesday | News
Labviva raises $20M in Series A to revolutionize life sciences procurement with AI

-Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million ...

March 28, 2023 | Tuesday | News
Imvax Announces First Patient Dosed in Phase 2b Trial of IGV-001 for Glioblastoma

-Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced dosing of the first pati...

March 28, 2023 | Tuesday | News
Teva's Collaboration with Rimidi Expands to Integrate Respiratory Monitoring with US Health System

California’s Desert Oasis Healthcare (DOHC) implements Rimidi’s Respiratory Module for respiratory patient monitoring, based on data collecte...

March 28, 2023 | Tuesday | News
New InnoGenomics Technology Revolutionizes DNA Testing of Sexual Assault Samples

Addressing a long-term shortcoming in DNA evidence for rape and sexual assault cases, New Orleans-based InnoGenomics has developed a nanotech method, Sperm...

March 28, 2023 | Tuesday | News
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and acc...

March 26, 2023 | Sunday | News
Premier Health amends circular and announces shareholder meeting results

Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announce...

March 26, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close